Awards Nomination 20+ Million Readerbase
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page
Journal Flyer
Journal of Bioequivalence & Bioavailability

Articles published in Journal of Bioequivalence & Bioavailability have been cited by esteemed scholars and scientists all around the world. Journal of Bioequivalence & Bioavailability has got h-index 26, which means every article in Journal of Bioequivalence & Bioavailability has got 26 average citations.

Following are the list of articles that have cited the articles published in Journal of Bioequivalence & Bioavailability.

  2022 2021 2020 2019 2018

Year wise published articles

60 61 19 6 27

Year wise citations received

394 412 405 380 363
Journal total citations count 4363
Journal Impact Factor 6.89
Journal 5 years Impact Factor 11.60
Journal CiteScore 14.43
Journal h-index 26
Important citations

Renati D, Vinay CV (2014) Role of novel hole technology in fast dissolving tablets. Journal of Molecular Pharmaceutics & Organic Process Research.

Chandra VV, Deepthi T, Sashikanth S, Lavanya Y, Damodar R (2014) Analysis of Sustained Unleash Indefinite Quantity Type of Anti-Diabetic Coordination of Deliquescent Polymers. J Mol Pharm Org Process Res, 2: R1-002.

Rao KM, FORMULATION AND EVALUATION OF PYRAZINAMIDE MATRIX TABLETS.

Varali S, Topical Dosage Forms of different Drugs by FDA: A Bioequivalence Study.

Pawar P (2016) Tools for real time release testing (RTRt) in batch and continuous tablet manufacturing (Doctoral dissertation, Rutgers University-Graduate School-New Brunswick).

Damodar R, Movva B (2014) Preparation and in-vitro evaluation of metformin HCl tablets containing sustained release beads for increasing therapeutic window. Journal of Bioequivalence & Bioavailability, 6: 91.

Morris J, Hirschi K, Yang J (2014) Biofortifying foods: tripping over high hurdles. Int J Biotechnol Food Sci, 2: 1-15.

Patil BS, Crosby K, Byrne D, Hirschi K (2014) The intersection of plant breeding, human health, and nutritional security: lessons learned and future perspectives. HortScience, 49: 116-127.

Chandra VV, Deepthi T, Sashikanth S, Lavanya Y,Damodar R (2014) Analysis of Sustained Unleash Indefinite Quantity Type of Anti-Diabetic Coordination of Deliquescent Polymers. J Mol Pharm Org Process Res, 2: R1-002.

Phiri K, Kimani J, Mtove GA, Zhao Q, Rojo R, et al. (2016) Parasitological Clearance Rates and Drug Concentrations of a Fixed Dose Combination of Azithromycin-Chloroquine in Asymptomatic Pregnant Women with Plasmodium Falciparum Parasitemia: An Open-Label, Non-Comparative Study in Sub-Saharan Africa. PloS one, 11: e0165692.

Chandra R, Ansah P, Sagara I, Sie A, Tiono AB, et al. (2015). Comparison of azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study. Malaria journal, 14: 108.

Zhao Q, Tensfeldt TG, Chandra R, Mould DR (2014) Population pharmacokinetics of azithromycin and chloroquine in healthy adults and paediatric malaria subjects following oral administration of fixed-dose azithromycin and chloroquine combination tablets. Malaria journal, 13: 36.

Ayrapetyan S (2016) Cell Hydration-induced Changes of Membrane Conductivity as a Marker for Estimation of Biological Effects of Chemical and Physical Factors on Organism. J Bioequiv Availab, 8: e72.

Ayrapetyan S (2015) The dysfunction of metabolic controlling of cell hydration precedes Warburg phenomenon in carcinogenesis. Journal of Bioequivalence & Bioavailability, 7: 1.

Macaluso M, Nichols AI, Preskorn SH (2015) How the Probability and Potential Clinical Significance of Pharmacokinetically Mediated Drug-Drug Interactions Are Assessed in Drug Development: Desvenlafaxine as an Example. The primary care companion for CNS disorders, 17(2).

Giguere P, Antidepressant Use in Hepatitis C: Level of Evidence for Prophylactic and Symptomatic Treatment of Depression in HCV and Actual/Potential Drug Interactions with Directly Acting Antivirals (DAAs).

Korth‐Bradley JM, Parks V, Wagner F, Chalon S, Gourley I, et al. (2014) Effect of moxidectin on CYP3A4 activity as evaluated by oral midazolam pharmacokinetics in healthy subjects. Clinical pharmacology in drug development, 3: 151-157.

Kornstein SG, McIntyre RS, Thase ME, Boucher M (2014) Desvenlafaxine for the treatment of major depressive disorder. Expert opinion on pharmacotherapy, 15: 1449-1463.

Faria MRSB (2015) Biossimilares: impacto global (Doctoral dissertation).

Silva CAG (2016) Contribuição ao estudo químico e de atividade biológica de Eugenia dysenterica Mart. ex. DC. Berg (Myrtaceae).